After more than a 30-year career in R&D for the pharmaceutical and medical diagnostics industry, Dmitriy started the D&L Consulting, Education and Services LLC in 2023. Prior to that, he spent 23 years developing PCR tests and platforms at Roche Group – a company that had acquired the original PCR patent from Cetus in 1992 and soon after launched the first commercial PCR assay. During those years he had the privilege of learning from the giants like R. Saiki, D. Gelfand and H. Erlich, leading the teams developing three automated PCR platforms and being part of paradigm shift in cervical cancer screening. He also had the honour of serving as an R&D lead for a record breaking 37 days product development of the first high throughput PCR-based SARS-CoV-2 test in 2020.